Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Clinical trial NCT01583218 · COMPLETED

Trial details

NCT number: NCT01583218
Sponsor: Portola Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism (VTE)

Start date: 2012-03-01
Primary completion: 2015-12-01
Enrollment: 7513

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.